News about Industrial talks

UK Accelerates Clinical Trials, Slashing Set-Up Time to Boost Patient Access

Government-backed reforms and Euro 137 million investment cut trial start times significantly, enabling faster access to innovative treatments through the National Health Service.

Industrial talks | 17/04/2026 | By News Bureau |  108

Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab

Adimab Collaborator GSK has received additional marketing approval for depemokimab, marking the sixth collaborator program to reach the market and strengthening its biologics portfolio.

Industrial talks | 17/04/2026 | By News Bureau |  120

NIPER Mohali Partners with Novartis to Support Faculty Research

NIPER Mohali signs grant agreement with Novartis Healthcare to support faculty research through development pioneer grant, strengthen industry-academia synergy, and boost innovation and R&D capabilities.

Industrial talks | 16/04/2026 | By News Bureau |  118

US Food and Drug Administration Urges Compliance on Clinical Trial Reporting to Address Data Gaps

The US Food and Drug Administration has issued reminders to over 2,200 companies and researchers to submit clinical trial results, aiming to reduce reporting gaps and improve transparency in drug development.

Industrial talks | 15/04/2026 | By News Bureau |  132

Indian Pharma's Turning Point: Can the Generics Giant Become a Global Innovator?

India’s pharma industry, long known as the “pharmacy of the world,” now aims to become an innovation hub. To understand this transition, Pharma Industrial India spoke to experts on moving beyond generics toward becoming an “innovator of the world.”

Industrial talks | 14/04/2026 | By Akanki |  306

Ofichem Group Unifies Global Brands Under Single Identity to Streamline Pharma Partnerships

Ofichem consolidates its global brands under one identity to deliver integrated pharmaceutical development and supply solutions.

Industrial talks | 11/04/2026 | By News Bureau |  168

TAE Life Sciences Study Highlights Next-Generation BNCT Platform with Tumour Control and Immune Activation Potential

TAE Life Sciences’ latest research demonstrates the potential of next-generation BNCT to combine targeted radiation with immune activation for improved cancer treatment outcomes.

Industrial talks | 11/04/2026 | By News Bureau

Domestic Momentum Fails to Offset US Pressure on Pharma Margins: Report

India’s pharmaceutical sector is expected to report steady domestic growth in Q4 FY26, but overall earnings are likely to come under pressure due to continued weakness in the US market, according to a report by Nuvama Institutional Equities.

Industrial talks | 10/04/2026 | By Darshana |  139

OPPI Partners with NIPER-Raebareli to Boost Pharma Research and Scholar Support

The collaboration between OPPI and NIPER-Raebareli will provide research scholarships, industry mentorship and academic support to strengthen innovation and bridge the gap between pharmaceutical research and real-world healthcare needs.

Industrial talks | 09/04/2026 | By News Bureau |  104

Soleno Withdraws EU Filing for Rare Disease Drug Ahead of Neurocrine Takeover

Soleno Therapeutics has withdrawn its European marketing application for Vykat XR, a treatment for hyperphagia associated with Prader-Willi syndrome, ahead of its planned acquisition by Neurocrine Biosciences.

Industrial talks | 09/04/2026 | By Darshana |  129